13-04-2025 02:17 via medpagetoday.com

Anti-CGRP Drug Reduces Episodic Migraine in Kids

(MedPage Today) -- SAN DIEGO--Fremanezumab (Ajovy) cut monthly migraine days in children and adolescents with episodic migraine, according to the SPACE trial.
The phase III study showed a reduction in monthly migraine days in patients (mean...
Read more »

Medical Industry news



Pridopidine Shows Promise in Subgroup of Huntington's Patients
'It Will Cost Lives': What We Heard This Week
Trump:'Fully Fit' to serve as Commander in Chief, Doctor Says
Estimated GFR Equation Matters When Dosing Chemotherapy in Cancer Patients
Removing Restraints: Reclaiming Patient Dignity in Delirium Care
Doctors Remove Pig Kidney From Alabama Woman After a Record 130 Days
Renal Outcomes Seem to Differ By Gender After Living Kidney Donation
Who Said RFK Jr. Should Be Fired?
Targeted Treatment Improves Disability in Guillain-Barre Syndrome
Healthy Aging and Diet; Global Effect of Cardiovascular Risk Factors
Private Equity's Growing Role in Disability Care Demands Urgent Oversight
States Advance Fetal Rights Measures That Critics Warn Could Lead to Abortion Bans
Retrospective Study Links COVID in Kids With Post-Acute Kidney Outcomes
U.S. Pregnancy-Related Deaths Rise Over 5 Years
Desktop versie